A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy
Research · 2025-01 · 8
DOI: 10.34133/research.0735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research, online erschienen am 17.06.2025. Verfasst von Chengjunyu Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for Central Universities.
Abstract (Originalsprache)
Ferroptosis has promising potential for augmenting antitumor effects, but monotherapy with ferroptosis inducers in vivo has been reported to have limited efficacy in tumor management. The development of synergistic strategies with targeted capabilities is crucial for enhancing the antitumor efficacy of ferroptosis inducers. In this study, we designed and characterized a novel self-assembled nanomedicine by mixing ferrous ions (Fe 2+ ) and epigallocatechin gallate (EGCG) in a controllable manner and encapsulating the ferroptosis inducer RSL3, named Fe-EGCG@RSL3. This multifunctional nanomedicine effectively induces ferroptosis and growth inhibition in bladder cancer cells and patient-derived organoids. In vivo, Fe-EGCG@RSL3 was enriched in the subcutaneous tumors of allogenic and xenograft mouse models, thereby substantially overcoming RSL3 resistance. Intravesical instillation of Fe-EGCG@RSL3 controls orthotopic bladder tumor progression. Furthermore, nanomedicine potentiates the therapeutic effect of anti-programmed cell death protein 1 (PD1) immunotherapy by increasing the cytotoxicity of CD8 + T cells to cancer cells and modulating the proportions of both T-cell and myeloid cell subpopulations within the tumor immune microenvironment. Overall, Fe-EGCG@RSL3 has dual functions as a multifaceted nanomedicine that integrates ferroptosis induction with immunomodulation, offering a novel and clinically translatable strategy for bladder cancer therapy.
Autor:innen und Institutionen
- Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
- Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
ORCID-Profile: Xu Chen
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Fundamental Research Funds for Central Universities
- Guangdong Provincial Clinical Research Centre for Urological Diseases
- Guangdong Science and Technology Department
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, C., Liu, S., Zhang, J., Lu, J., Chen, Z., Pan, B., Liu, C., Huang, M., Zhan, H., Wang, H., Chen, S., Jie, K., He, B., Wu, J., Li, Y., Wang, H., Zhao, J., Zhang, Q., & Chen, X. (2025). A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy. Research, 8. https://doi.org/10.34133/research.0735
Vancouver
Zhang C, Liu S, Zhang J, Lu J, Chen Z, Pan B, et al. A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy. Research. 2025;8. doi:10.34133/research.0735
BibTeX
@article{Zhang2025,
author = {Zhang, Chengjunyu and Liu, Sen and Zhang, Jianhui and Lu, Junlin and Chen, Zehua and Pan, Bolin and Liu, Chu and Huang, Ming and Zhan, Hengji and Wang, Hongjin and Chen, Siting and Jie, Kaiwen and He, Baoqing and Wu, Jingdie and Li, Ye and Wang, Haifeng and Zhao, Jing and Zhang, Qiang and Chen, Xu},
title = {A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy},
journal = {Research},
year = {2025},
volume = {8},
doi = {10.34133/research.0735}
}
EUVIMED